Jeong Kim

7.0k total citations · 5 hit papers
18 papers, 5.2k citations indexed

About

Jeong Kim is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jeong Kim has authored 18 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 10 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Jeong Kim's work include Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (9 papers) and Immunotherapy and Immune Responses (7 papers). Jeong Kim is often cited by papers focused on Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (9 papers) and Immunotherapy and Immune Responses (7 papers). Jeong Kim collaborates with scholars based in United States, France and Australia. Jeong Kim's co-authors include Alexander Y. Rudensky, Jeffrey P. Rasmussen, Ira Mellman, Jeanne Cheung, Dibyendu K. Sasmal, Xiaolei Su, Enfu Hui, Jun Huang, Heidi Ackerly Wallweber and Marcus J. Taylor and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Jeong Kim

16 papers receiving 5.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

2006 1.4k citations Jeong Kim, Jeffrey P. Rasmussen et al. Nature Immunology profile →
T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition

2017 1.2k citations Enfu Hui, Jeanne Cheung et al. Science profile →
Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses

2009 735 citations Ye Zheng, Ashutosh Chaudhry et al. Nature profile →
MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade

2016 527 citations Peter Ebert, Jeanne Cheung et al. Immunity profile →
PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer

2020 316 citations Soyoung Oh, Dai-Chen Wu et al. Nature Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeong Kim United States	13	3.9k	2.2k	1.0k	272	265	18	5.2k
Mark P. Rubinstein United States	32	3.4k 0.9×	2.1k 0.9×	817 0.8×	177 0.7×	339 1.3×	76	4.6k
Yasutoshi Agata Japan	21	3.5k 0.9×	2.8k 1.3×	1.3k 1.3×	402 1.5×	401 1.5×	35	5.5k
Firouzeh Korangy United States	38	4.0k 1.0×	2.5k 1.1×	1.3k 1.2×	359 1.3×	420 1.6×	71	5.7k
Wojciech Szeliga United States	19	4.0k 1.0×	3.0k 1.3×	1.5k 1.4×	367 1.3×	564 2.1×	26	5.7k
Sophie Lucas Belgium	38	4.5k 1.2×	2.0k 0.9×	2.1k 2.1×	313 1.2×	218 0.8×	71	5.8k
Segundo González Spain	44	3.5k 0.9×	1.6k 0.7×	845 0.8×	162 0.6×	291 1.1×	109	5.2k
Lucia Gabriele Italy	35	2.5k 0.7×	1.5k 0.7×	1.1k 1.1×	185 0.7×	363 1.4×	74	4.3k
Nicole M. Haynes Australia	31	2.6k 0.7×	2.3k 1.0×	1.1k 1.1×	230 0.8×	177 0.7×	58	4.2k
Richard V. Parry United Kingdom	23	3.0k 0.8×	2.2k 1.0×	1.3k 1.3×	250 0.9×	440 1.7×	32	4.6k
Cindy Sander United States	28	3.6k 0.9×	3.7k 1.7×	1.2k 1.2×	353 1.3×	330 1.2×	84	5.2k

Countries citing papers authored by Jeong Kim

Since Specialization

Citations

This map shows the geographic impact of Jeong Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeong Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeong Kim more than expected).

Fields of papers citing papers by Jeong Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeong Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeong Kim. The network helps show where Jeong Kim may publish in the future.

Co-authorship network of co-authors of Jeong Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Jeong Kim. A scholar is included among the top collaborators of Jeong Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeong Kim. Jeong Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Almeida, Patricia E. de, Judy Mak, Genevive Hernandez, et al.. (2020). Anti-VEGF Treatment Enhances CD8+ T-cell Antitumor Activity by Amplifying Hypoxia. Cancer Immunology Research. 8(6). 806–818. 80 indexed citations

Oh, Soyoung, Dai-Chen Wu, Jeanne Cheung, et al.. (2020). PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer. Nature Cancer. 1(7). 681–691. 316 indexed citations breakdown →

Du, Changchun, Jack Bevers, Ryan Cook, et al.. (2019). MICA immune complex formed with alpha 3 domain-specific antibody activates human NK cells in a Fc-dependent manner. Journal for ImmunoTherapy of Cancer. 7(1). 207–207. 20 indexed citations

Hernandez, Sairy, Qing Jing, Xiangnan Du, et al.. (2018). The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function. Cell Reports. 25(1). 80–94. 76 indexed citations

Hui, Enfu, Jeanne Cheung, Jing Zhu, et al.. (2017). T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition. Science. 355(6332). 1428–1433. 1180 indexed citations breakdown →

Lau, Janet, Jeanne Cheung, Armando Navarro, et al.. (2017). Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice. Nature Communications. 8(1). 14572–14572. 270 indexed citations

Suto, Eric, Arthur Wüster, Jeffrey Eastham‐Anderson, et al.. (2017). The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice. The Journal of Immunology. 199(4). 1238–1249. 33 indexed citations

Ebert, Peter, Jeanne Cheung, Yagai Yang, et al.. (2016). MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade. Immunity. 44(3). 609–621. 527 indexed citations breakdown →

Ziai, James, Houston Gilbert, Oded Foreman, et al.. (2015). Heterogeneity of cytotoxic T cell infiltration in breast and colorectal cancer. Journal for ImmunoTherapy of Cancer. 3(S2).

10.

Ziai, James, Gretchen Frantz, Ping Zhang, et al.. (2015). Prevalence analysis of OX40-positive cell populations in solid tumors. Journal for ImmunoTherapy of Cancer. 3(S2). 1 indexed citations

11.

Kim, Jeong. (2015). Abstract DDT01-02: Unleashing anti-tumor immunity through anti-OX40 monotherapy and in combination with anti-PD-L1. Cancer Research. 75(15_Supplement). DDT01–2.

12.

Samstein, Robert, Aaron Arvey, Steven Z. Josefowicz, et al.. (2012). Foxp3 Exploits a Pre-Existent Enhancer Landscape for Regulatory T Cell Lineage Specification. Cell. 151(1). 153–166. 356 indexed citations

13.

Kim, Jeong. (2010). Molecular Mechanisms of Regulatory T Cell Development and Suppressive Function. Progress in molecular biology and translational science. 92. 279–314. 6 indexed citations

14.

Liston, Adrian & Jeong Kim. (2009). Short‐circuiting regulatory T‐cell proliferation during chronic infection. Immunology and Cell Biology. 87(6). 443–444. 1 indexed citations

15.

Zheng, Ye, Ashutosh Chaudhry, Arnold Kas, et al.. (2009). Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses. Nature. 458(7236). 351–356. 735 indexed citations breakdown →

16.

Lee, Sun‐Young, Hye Sung Han, Kyung Lee, et al.. (2007). Sonic hedgehog expression in gastric cancer and gastric adenoma. Oncology Reports. 17(5). 1051–5. 48 indexed citations

17.

Kim, Jeong, Jeffrey P. Rasmussen, & Alexander Y. Rudensky. (2006). Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nature Immunology. 8(2). 191–197. 1398 indexed citations breakdown →

18.

Kim, Jeong & Alexander Y. Rudensky. (2006). The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunological Reviews. 212(1). 86–98. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact